Inventor · disambiguated record
Chandramouli Chillakuri
Also filed as: CHILLAKURI CHANDRAMOULI · CHILLAKURI CHANDRAMOULI REDDY
5 granted patents·14 pending applications·6 citations·filing 2016–2024
70Inventor score
Files withIMMUNOCORE LTD19
Top patents by PatentIndex Score
19 records- 0187US12134647B2Binding moleculesIMMUNOCORE LTD·Filed 2024·Granted Nov 5, 2024·3 cites·22 claims
- 0284US12195534B2Binding moleculesIMMUNOCORE LTD·Filed 2024·Granted Jan 14, 2025·2 cites·22 claims
- 0378US2025134956A1Peptides derived from kita-kyushu lung cancer antigen (kklc1, ct83, cxorf61) and complexes comprising such peptides bound to mhc moleculesIMMUNOCORE LTD·Filed 2024·Application pending·0 cites
- 0473US10835577B2Peptides derived from Kita-kyushu lung cancer antigen (KKLC1, CT83, CXorf61) and complexes comprising such peptides bound to MHC moleculesIMMUNOCORE LTD·Filed 2016·Granted Nov 17, 2020·1 cites·10 claims
- 0570US2023330181A1Peptides derived from kita-kyushu lung cancer antigen (kklc1, ct83, cxorf61) and complexes comprising such peptides bound to mhc moleculesIMMUNOCORE LTD·Filed 2023·Application pending·0 cites
- 0669US2025026829A1Binding moleculesIMMUNOCORE LTD·Filed 2024·Application pending·0 cites
- 0766US2025179178A1Binding moleculesIMMUNOCORE LTD·Filed 2024·Application pending·0 cites
- 0861US2021121526A1Peptides derived from kita-kyushu lung cancer antigen (kklc1, ct83, cxorf61) and complexes comprising such peptides bound to mhc moleculesIMMUNOCORE LTD·Filed 2020·Application pending·0 cites
- 0961US2021322528A1Peptides from npsr1IMMUNOCORE LTD·Filed 2021·Application pending·0 cites
- 1058US11739441B2TCR librariesIMMUNOCORE LTD·Filed 2021·Granted Aug 29, 2023·0 cites·1 claims
- 1154US2021138054A1Peptides derived from prostate specific antigen (klk3) and complexes comprising such peptides bound to mhc moleculesIMMUNOCORE LTD·Filed 2020·Application pending·0 cites
- 1251US2021017227A1PeptidesIMMUNOCORE LTD·Filed 2020·Application pending·0 cites
- 1350US11136575B2TCR librariesIMMUNOCORE LTD·Filed 2016·Granted Oct 5, 2021·0 cites·19 claims
- 1449US2018339027A1Peptides from npsr1IMMUNOCORE LTD·Filed 2016·Application pending·0 cites
- 1548US2024190969A1Specific binding moleculesIMMUNOCORE LTD·Filed 2020·Application pending·0 cites
- 1648US2023348595A1Soluble tcrs and fusions to anti-cd3 recognizing kras g12d for the treatment of cancerIMMUNOCORE LTD·Filed 2021·Application pending·0 cites
- 1747US2018339028A1PeptidesIMMUNOCORE LTD·Filed 2016·Application pending·0 cites
- 1841US2018334476A1PeptidesIMMUNOCORE LTD·Filed 2016·Application pending·0 cites
- 1936US2021115099A1PeptidesIMMUNOCORE LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →